Smith Hayes Advisers’s Gilead Sciences GILD Stock Holding History

Smith Hayes Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$577K	Sell	6,282 -6,102	-49%	-$550K	0.12%	187
2015 Q4	$1.25M	Sell	12,384 -422	-3%	-$43.9K	0.26%	104
2015 Q3	$1.26M	Buy	12,806 +49	+0.4%	+$5.44K	0.27%	105
2015 Q2	$1.49M	Buy	12,757 +1,850	+17%	+$202K	0.3%	101
2015 Q1	$1.07M	Buy	10,907 +1,318	+14%	+$134K	0.21%	124
2014 Q4	$904K	Buy	9,589 +7,568	+374%	+$783K	0.19%	139
2014 Q3	$215K	Buy	+2,021	New	+$198K	0.05%	264

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Smith Hayes Advisers's GILD Position: Q1 2016 in Review

Smith Hayes Advisers reduced its Gilead Sciences (GILD) stake by 49% in Q1 2016, selling an estimated $550K and leaving 6,282 shares worth $577K. The position accounts for 0.12% of the portfolio, ranked #187.

Smith Hayes Advisers first reported a position in GILD in Q3 2014 and has held it in 7 quarters since. The position peaked at $1.49M in Q2 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Smith Hayes Advisers held 6,282 shares of Gilead Sciences worth $577K as of Q1 2016.
Smith Hayes Advisers sold 6,102 Gilead Sciences shares in Q1 2016, an estimated $550K.
Gilead Sciences made up 0.12% of Smith Hayes Advisers's portfolio in Q1 2016, its #187 holding.
Smith Hayes Advisers first reported a position in Gilead Sciences in Q3 2014 and has held it in 7 quarters since.
Smith Hayes Advisers's Gilead Sciences position peaked at $1.49M in Q2 2015.
1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.